0001410939-22-000073.txt : 20220516
0001410939-22-000073.hdr.sgml : 20220516
20220516182355
ACCESSION NUMBER: 0001410939-22-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220512
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Christine Ann
CENTRAL INDEX KEY: 0001903530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 22931523
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA, SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: (609) 474-6755
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
wf-form4_165273981040409.xml
FORM 4
X0306
4
2022-05-12
0
0001410939
IVERIC bio, Inc.
ISEE
0001903530
Miller Christine Ann
C/O IVERIC BIO, INC.
8 SYLVAN WAY
PARSIPPANY
NJ
07054
1
0
0
0
Restricted Stock Units
2022-05-12
4
A
0
8075
0
A
Common Stock
8075.0
8075
D
Stock Option (right to buy)
9.94
2022-05-12
4
A
0
12835
0
A
2032-05-11
Common Stock
12835.0
12835
D
Restricted stock units will convert into common stock on a one-for-one basis upon vesting of the units.
In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 8,075 restricted stock units. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of the business day immediately prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan).
In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted a stock option to purchase 12,835 shares of the Registrant's common stock. Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest monthly with respect to 1/12 of the shares underlying such stock option award until the earlier of the business day immediately prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the stock option award will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan).
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christine Miller
2022-05-16